EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Utility of Artificial Intelligence for Decision Making in Thoracic Multidisciplinary Tumor Boards

Jon Zabaleta iD, Borja Aguinagalde iD, Iker Lopez iD, Arantza Fernandez-Monge, Jon A Lizarbe iD, Maria Mainer iD, Juan A Ferrer-Bonsoms iD, Mateo de Assas

Journal of Clinical Medicine · 10.01.2025 · 14 (2) · 399

DOI: 10.3390/jcm14020399 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 10.01.2025. Verfasst von Jon Zabaleta und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Basque Health Service, Donostialdea Integrated Health Organisation, 20014 San Sebastian, Spain. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: The aim of this study was to analyze whether the implementation of artificial intelligence (AI), specifically the Natural Language Processing (NLP) branch developed by OpenAI, could help a thoracic multidisciplinary tumor board (MTB) make decisions if provided with all of the patient data presented to the committee and supported by accepted clinical practice guidelines.

Methods

This is a retrospective comparative study. The inclusion criteria were defined as all patients who presented at the thoracic MTB with a suspicious or first diagnosis of non-small-cell lung cancer between January 2023 and June 2023.

Intervention

GPT 3.5 turbo chat was used, providing the clinical case summary presented in committee proceedings and the latest SEPAR lung cancer treatment guidelines. The application was asked to issue one of the following recommendations: follow-up, surgery, chemotherapy, radiotherapy, or chemoradiotherapy. Statistical analysis: A concordance analysis was performed by measuring the Kappa coefficient to evaluate the consistency between the results of the AI and the committee’s decision.

Results

Fifty-two patients were included in the study. The AI had an overall concordance of 76%, with a Kappa index of 0.59 and a consistency and replicability of 92.3% for the patients in whom it recommended surgery (after repeating the cases four times).

Conclusions

AI is an interesting tool which could help in decision making in MTBs.

Schlagwörter

Stichwörter der Autor:innen

artificial intelligence (AI)decision makinglung cancermultidisciplinary tumor board

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Basque Health Service, Donostialdea Integrated Health Organisation, 20014 San Sebastian, Spain.
  • Tecnun, School of Engineering, University of Navarra, 20018 San Sebastian, Spain.

ORCID-Profile: Jon Zabaleta, Borja Aguinagalde, Iker Lopez, Jon A Lizarbe, Maria Mainer, Juan A Ferrer-Bonsoms

Zitieren

APA

Zabaleta, J., Aguinagalde, B., Lopez, I., Fernandez-Monge, A., Lizarbe, J. A., Mainer, M., Ferrer-Bonsoms, J. A., & de Assas, M. (2025). Utility of Artificial Intelligence for Decision Making in Thoracic Multidisciplinary Tumor Boards. Journal of Clinical Medicine, 14(2), 399. https://doi.org/10.3390/jcm14020399

Vancouver

Zabaleta J, Aguinagalde B, Lopez I, Fernandez-Monge A, Lizarbe JA, Mainer M, et al. Utility of Artificial Intelligence for Decision Making in Thoracic Multidisciplinary Tumor Boards. Journal of Clinical Medicine. 2025;14(2):399. doi:10.3390/jcm14020399

BibTeX
@article{Zabaleta2025,
  author = {Zabaleta, Jon and Aguinagalde, Borja and Lopez, Iker and Fernandez-Monge, Arantza and Lizarbe, Jon A and Mainer, Maria and Ferrer-Bonsoms, Juan A and de Assas, Mateo},
  title = {Utility of Artificial Intelligence for Decision Making in Thoracic Multidisciplinary Tumor Boards},
  journal = {Journal of Clinical Medicine},
  year = {2025},
  volume = {14},
  number = {2},
  pages = {399},
  doi = {10.3390/jcm14020399}
}
Kostenlos starten →